Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers
RNA Interference (RNAi) has brought revolutionary transformations in cancer management in the past two decades. RNAi-based therapeutics including siRNA and shRNA have immense scope to silence the expression of mutant cancer genes specifically in a therapeutic context. Although tremendous progress ha...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2018-05-01
|
| シリーズ: | Pharmaceutics |
| 主題: | |
| オンライン・アクセス: | http://www.mdpi.com/1999-4923/10/2/65 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
